CD34 Enrichment & Hematopoietic Stem Cell Therapy
High-Purity Isolation for Regenerative Medicine
Precision CD34+ stem cell enrichment from bone marrow, peripheral blood, or umbilical cord blood — powering blood disorders treatment, cardiovascular repair, and beyond.
CD34 Enrichment is a specialized laboratory technique used to isolate CD34+ hematopoietic stem cells from bone marrow, peripheral blood, or umbilical cord blood. These stem cells are essential for generating new blood cells, repairing tissues, and supporting regenerative medicine. By enriching CD34+ cells, clinicians enhance the success of stem cell therapy and other advanced treatments.
What are CD34+ Hematopoietic Stem Cells?
Hematopoietic Stem Cells (HSCs)
CD34+ cells give rise to red blood cells, white blood cells, and platelets.
Marker of Regeneration
CD34 is a key surface protein used in stem cell isolation for regenerative therapies.
Multipotent Potential
These cells migrate to damaged tissues, reduce inflammation, and promote healing.
How CD34 Enrichment Works
Step 1 – Cell Collection
Harvested from bone marrow, peripheral blood, or umbilical cord blood.
Step 2 – Separation
CD34+ stem cells are isolated using magnetic-activated cell sorting (MACS) or fluorescence-activated cell sorting (FACS).
Step 3 – Enrichment
The purified CD34+ population is concentrated for clinical use.
Clinical Applications of CD34 Enrichment
- 1
Bone Marrow Transplantation
Treats blood cancers like leukemia and lymphoma.
- 2
Cardiovascular Repair
Supports blood vessel regeneration in ischemic heart disease and PAD.
- 3
Neurological Disorders
Aids recovery in ALS, Parkinson's, and spinal cord injuries.
- 4
Wound Healing
Enhances angiogenesis in chronic wounds and diabetic ulcers.
Advantages of CD34 Enrichment
- ✓
High Purity
Delivers targeted regenerative cells with reduced rejection risk.
- ✓
Personalized Therapy
Enables patient-specific stem cell therapy.
- ✓
Enhanced Efficacy
Optimized enrichment improves treatment outcomes.
- ✓
Reduced Side Effects
Safer compared to non-enriched bone marrow transplants.
Safety & Innovation
All CD34 Enrichment procedures are performed under GMP-certified conditions using advanced technologies like MACS and FACS. The process ensures viability, sterility, and precision dosing for safe clinical applications.
CD34 Enrichment at Genestac Therapeutics
At Genestac Therapeutics, we provide advanced CD34 Enrichment services for stem cell therapy and regenerative medicine. Our expertise ensures:
- ✓High-yield stem cell recovery
- ✓Customized cell dosing for patients
- ✓Immune profiling and diagnostics
- ✓Safe infusion with post-therapy monitoring
CD34 Enrichment is transforming the future of regenerative medicine by improving the precision and outcomes of stem cell therapy. With Genestac's innovation and clinical expertise, patients gain access to cutting-edge solutions for blood disorders, neurological conditions, and cardiovascular repair.
Frequently Asked Questions
Who is eligible for CD34 cell therapy?
Patients with blood disorders such as leukemia, lymphoma, aplastic anemia, or sickle cell disease are primary candidates. Those requiring cardiovascular regeneration, neurological recovery, or with severe wounds that are unresponsive to conventional treatments may also benefit from CD34+ cell therapy.
Is CD34 Enrichment safe?
Yes. CD34 Enrichment is a well-established, GMP-certified procedure. Using closed-system MACS or FACS sorting minimizes contamination risks. The isolated cells are quality-tested for viability, purity, and sterility before clinical administration.
How long do the effects of CD34 therapy last?
The duration varies by indication. For bone marrow transplants, successful engraftment can provide permanent restoration of healthy hematopoiesis. For cardiovascular or wound healing applications, clinical benefits have been observed for 6–24 months with some studies showing durable improvements beyond that timeframe.
Start Your Healing Journey Today
Take the first step towards recovery with our expert team at Genestac Therapeutics — leaders in regenerative medicine.
